4. Dixon DW. Opioid Abuse. Medscape. 2023. https://emedicine.medscape.com/article/287790-overview#a1
5. Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015 Sep-Oct;9(5):358-67
7. Yakovenko I, Mukaneza Y, Germé K, et al; Canadian Research Initiative in Substance Matters guideline development team. Management of opioid use disorder: 2024 update to the national clinical practice guideline. CMAJ. 2024 Nov 11;196(38):E1280-E1290. doi: 10.1503/cmaj.241173.
8. Veilleux JC, Clovin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review. 2010;30:155–66.
9. Boyer EW. Management of Opioid Analgesic Overdose. N Eng J Med. 2012;367:146-55
16. Fareed A, Stout S, Casarella J, Vayalapalli S, Cox J, Drexler K. Substance Abuse: Research and Treatment 2011:5 17–25
19. Leon-Barriera R, Zwiebel SJ, Modesto-Lowe V. A practical guide for buprenorphine initiation in the primary care setting. Cleveland Clinic Journal of Medicine September 2023, 90 (9) 557-564; DOI: https://doi.org/10.3949/ccjm.90a.23022
20. Nicholls L, Bragaw L, Ruetsch C. Opioid Dependence Treatment and Guidelines. Journal of Managed Care Pharmacy, 2010. 16(1 Supp B): 14–21.v doi:10.18553/jmcp.2010.16.s1-b.14
21. Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews 2011, Issue 4. DOI: 10.1002/14651858.CD001333.pub4.